Literature DB >> 33982587

Effects of H3 and H4 histones acetylation and bindings of CREB binding protein and p300 at the promoter on hepatic expression of gamma-glutamyltransferase gene in a streptozotocin-induced moderate hypoinsulinemic rat model.

T Tanaka1, T Mizuno, T Nakagawa, T Hayakawa, M Shimada.   

Abstract

Gamma-glutamyltransferase (GGT), a marker of liver disease, has been shown to be associated with increased risk of diabetes and relative insulin secretion deficiency. However, the mechanism of hepatic Ggt regulation has not been explored fully. In this study, we made a concerted effort to understand the mechanism by investigating the effects of acetylation of histones H3 and H4, and bindings of histone acetyltransferases, CREB binding protein (CBP) and p300, at the Ggt promoter on the regulation of the expression of Ggt gene in the livers of streptozotocin (STZ)-induced moderate hypoinsulinemia rat model. The rats treated with STZ showed remarkably higher serum GGT level and hepatic Ggt/GGT expression than the untreated control rats. Furthermore, the acetylation of histones H3 and H4, and the binding of CBP not p300 at the Ggt promoter regions were significantly higher in the livers of STZ rats than those of the control rats. These results suggest that an enhanced hepatic expression of Ggt is associated with increased acetylation of histones H3 and H4 and CBP binding at the Ggt promoter in STZ-induced moderate hypoinsulinemic rats.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33982587      PMCID: PMC8820556          DOI: 10.33549/physiolres.934620

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  18 in total

1.  Diabetic complications are associated with liver enzyme activities in people with type 1 diabetes.

Authors:  P E Arkkila; P J Koskinen; I M Kantola; T Rönnemaa; E Seppänen; J S Viikari
Journal:  Diabetes Res Clin Pract       Date:  2001-05       Impact factor: 5.602

Review 2.  CREB and the CRTC co-activators: sensors for hormonal and metabolic signals.

Authors:  Judith Y Altarejos; Marc Montminy
Journal:  Nat Rev Mol Cell Biol       Date:  2011-03       Impact factor: 94.444

3.  High-Fructose Diet-Induced Hypertriglyceridemia Is Associated With Enhanced Hepatic Expression of ACAT2 in Rats.

Authors:  Y Ichigo; A Takeshita; M Hibino; T Nakagawa; T Hayakawa; D Patel; C J Field; M Shimada
Journal:  Physiol Res       Date:  2019-10-25       Impact factor: 1.881

4.  New evidence for an association between liver enzymes and pancreatic islet β-cell dysfunction in young obese patients.

Authors:  Li Wang; Juanjuan Zhang; Bokai Wang; Yuwen Zhang; Jie Hong; Yifei Zhang; Weiqing Wang; Weiqiong Gu
Journal:  Endocrine       Date:  2013-04-03       Impact factor: 3.633

5.  Insulin-induced inhibition of gluconeogenesis genes, including glutamic pyruvic transaminase 2, is associated with reduced histone acetylation in a human liver cell line.

Authors:  Kazue Honma; Michiko Kamikubo; Kazuki Mochizuki; Toshinao Goda
Journal:  Metabolism       Date:  2017-03-23       Impact factor: 8.694

6.  Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein.

Authors:  Ling He; Amin Sabet; Stephen Djedjos; Ryan Miller; Xiaojian Sun; Mehboob A Hussain; Sally Radovick; Fredric E Wondisford
Journal:  Cell       Date:  2009-05-15       Impact factor: 41.582

7.  Clinical association between serum γ-glutamyltransferase levels and the development of insulin resistance in Korean men: a 5-year follow-up study.

Authors:  J H Ryoo; C M Oh; H S Kim; S K Park; J M Choi
Journal:  Diabet Med       Date:  2013-10-09       Impact factor: 4.359

Review 8.  Gamma-glutamyltransferase-friend or foe within?

Authors:  Setor K Kunutsor
Journal:  Liver Int       Date:  2016-08-31       Impact factor: 5.828

Review 9.  p300/CBP proteins: HATs for transcriptional bridges and scaffolds.

Authors:  H M Chan; N B La Thangue
Journal:  J Cell Sci       Date:  2001-07       Impact factor: 5.285

10.  Elevated serum gamma-glutamyltransferase is a strong marker of insulin resistance in obese children.

Authors:  Seon Yeong Lee; Eunju Sung; Yoosoo Chang
Journal:  Int J Endocrinol       Date:  2013-03-12       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.